Sales Estimate For Aduro BioTech Inc (NASDAQ:ADRO) At $144.695 - Investor Newswire
Sales Estimate For Aduro BioTech Inc (NASDAQ:ADRO) At $144.695
Investor Newswire
The average sales forecast for Aduro BioTech Inc (NASDAQ:ADRO) is $144.695 in 2016 whereas the median is $144.695 as anticipated by 2 experts for the period ended 4. Sales forecasting is measured as one of the requisites in planning processes.
Read more »